Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.
Join Mergr to view all 179 acquisitions of life science companies in 2013, including 20 acquisitions by private equity firms, and 159 by strategics.
249 E. Grand Avenue,
South San Francisco, California 94080
Onyx Pharmaceuticals was acquired by Amgen on August 25, 2013.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Onyx Pharmaceuticals.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.